LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback